News

Published on 28 Sep 2021 on Olean Times Herald

NY's bowhunting season starts Friday; Pa.'s starts Saturday


Article preview image

Bowhunting seasons for deer and bear in New York’s Southern Zone get underway Thursday, with several...

NASDAQ.AXSM price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Insider Sell: COO Mark Jacobson Sells 24,662 Shares of Axsome Therapeutics Inc (AXSM)

Axsome Therapeutics Inc (NASDAQ:AXSM), a biopharmaceutical company focused on developing novel th...

GuruFocus.com via Yahoo Finance 2 Apr 2024

30 Countries with the Lowest Depression Rates

In this article, we will be taking a look at the 30 countries with the lowest depression rates. I...

Insider Monkey via Yahoo Finance 26 Mar 2024

Axsome's (AXSM) Narcolepsy Drug Study Meets Primary Goal

Axsome Therapeutics AXSM announced encouraging data from the phase III SYMPHONY study on its inve...

Zacks via Yahoo Finance 26 Mar 2024

20 Cloudiest Cities in the U.S., Ranked

In this article, we will take a look at the top 20 cloudiest cities in the U.S., Ranked. If you w...

Insider Monkey via Yahoo Finance 25 Mar 2024

What's Going On Neurology-Focused Axsome Therapeutics' Stock On Monday? - Axsome Therapeutics...

Monday, Axsome Therapeutics Inc AXSM released data from the SYMPHONY Phase 3 trial of AXS-12 (reb...

Benzinga 25 Mar 2024

Narcolepsy patients report high symptom persistence By Investing.com

Axsome Therapeutics, Inc. (NASDAQ:AXSM), a company focused on developing therapies for central...

Investing.com 25 Mar 2024

AXS-12 shows promise in narcolepsy treatment, trial finds By Investing.com

Axsome Therapeutics, Inc. (NASDAQ: NASDAQ:AXSM), a biopharmaceutical company, announced today...

Investing.com 25 Mar 2024

Axsome Triumphs Over Major Depressive Disorder With Auvelity

Axsome Therapeutics Inc. (NASDAQ:AXSM) is a fast-growing pharmaceutical company headquartered in ...

GuruFocus.com via Yahoo Finance 22 Mar 2024

Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More

It was a busy week for the biotech sector with lots of study data readouts and regulatory approva...

Zacks via Yahoo Finance 21 Mar 2024

Axsome (AXSM) Begins Dosing in Depression Study on Sunosi

Axsome Therapeutics, Inc. AXSM announced that it has dosed the first patient in the phase III PAR...

Zacks via Yahoo Finance 20 Mar 2024